Abstract Purpose This study investigated changes in retinal vessel density in macular and papillary regions in post-SARS-CoV-2 pneumonia patients by means of optical coherence tomography angiography (OCTA). Design Prospective, observational,…
Purpose To compare the outcomes of Aurolab aqueous drainage implant (AADI; Aurolab) placement and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to aniridia. Design Retrospective comparative interventional…
Purpose: We sought to characterize juxtapapillary (JP) and non-JP microvasculature dropout in patients with primary open-angle glaucoma and to compare their rate of retinal nerve fiber layer (RNFL) thinning. Design:…
Highlights • No statistical difference exists in endophthalmitis rate between moxifloxacin and cefuroxime. • Successful endophthalmitis prophylaxis depends on intracameral moxifloxacin dose. • Intracameral cefuroxime does not cover Enterococcus and…
Abstract Purpose: To describe the prevalence and spectrum of disease of pentosan polysulfate (PPS) maculopathy in a large multimodal retinal imaging study and to report the results of choroidal vascularity index…
Purpose To assess the prevalence of ophthalmic findings in patients with Darier disease, an autosomal dominant genetic skin disorder, in an effort to evaluate the need for eye examinations in…
Purpose To assess potential associations between the prevalence of age-related macular degeneration (AMD) and systemic parameters in a Chinese population. Design Cross-sectional study. Methods The Tongren Health Care Study included…
Purpose To evaluate the effect of select baseline characteristics on geographic atrophy (GA) progression in eyes receiving intravitreal pegcetacoplan or sham. Design Phase 2 multicenter, randomized, single-masked, sham-controlled trial. Methods…
Purpose To (1) use All of Us ( AoU ) data to validate a previously published single-center model predicting the need for surgery among individuals with glaucoma, (2) train new…
Highlights • From baseline to week 76, 65.6% of patients gained ≥15 letters. • In the treat-and-extend phase, 45.0% of patients achieved a mean treatment interval of ≥8 weeks. •…
